Works by Holst, Jens J.

Results: 484
    1
    2

    One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3213, doi. 10.3390/jcm9103213
    By:
    • Vedtofte, Louise;
    • Bahne, Emilie;
    • Foghsgaard, Signe;
    • Bagger, Jonatan I.;
    • Andreasen, Camilla;
    • Strandberg, Charlotte;
    • Gørtz, Peter M.;
    • Holst, Jens J.;
    • Grønbæk, Henning;
    • Svare, Jens A.;
    • Clausen, Tine D.;
    • Mathiesen, Elisabeth R.;
    • Damm, Peter;
    • Gluud, Lise L.;
    • Knop, Filip K.;
    • Vilsbøll, Tina
    Publication type:
    Article
    3
    4

    Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4905, doi. 10.1111/dom.15889
    By:
    • Dejgaard, Thomas F.;
    • Frandsen, Christian S.;
    • Kielgast, Urd;
    • Størling, Joachim;
    • Overgaard, Anne J.;
    • Svane, Maria S.;
    • Olsen, Markus Harboe;
    • Thorsteinsson, Birger;
    • Andersen, Henrik U.;
    • Krarup, Thure;
    • Holst, Jens J.;
    • Madsbad, Sten
    Publication type:
    Article
    5

    Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3213, doi. 10.1111/dom.15649
    By:
    • Svensson, Cecilie H.;
    • Fabricius, Therese W.;
    • Verhulst, Clementine E. M.;
    • Kristensen, Peter L.;
    • Tack, Cees J.;
    • Heller, Simon R.;
    • Amiel, Stephanie A.;
    • McCrimmon, Rory J.;
    • Evans, Mark;
    • Holst, Jens J.;
    • de Galan, Bastiaan E.;
    • Pedersen‐Bjergaard, Ulrik
    Publication type:
    Article
    6
    7

    Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52‐week randomized controlled clinical trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 201, doi. 10.1111/dom.15306
    By:
    • Foghsgaard, Signe;
    • Vedtofte, Louise;
    • Andersen, Emilie S.;
    • Bahne, Emilie;
    • Andreasen, Camilla;
    • Sørensen, Anne L.;
    • Forman, Julie L.;
    • Mathiesen, Elisabeth R.;
    • Svare, Jens A.;
    • Clausen, Tine D.;
    • Damm, Peter;
    • Holst, Jens J.;
    • Knop, Filip K.;
    • Vilsbøll, Tina
    Publication type:
    Article
    8
    9

    Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1632, doi. 10.1111/dom.15017
    By:
    • Nerild, Henriette H.;
    • Brønden, Andreas;
    • Gether, Ida M.;
    • Hellmann, Pernille H.;
    • Baekdal, Mille;
    • Gillum, Matthew P.;
    • Svenningsen, Jens S.;
    • Hartmann, Bolette;
    • Rathor, Naveen;
    • Kudiyanur Muniraju, Hanna Angelene;
    • Rehfeld, Jens F.;
    • Holst, Jens J.;
    • Vilsbøll, Tina;
    • Sonne, David P.;
    • Knop, Filip K.
    Publication type:
    Article
    10
    11

    A randomized, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 98, doi. 10.1111/dom.14851
    By:
    • Juhl, Christian R.;
    • Burgdorf, Josephine;
    • Knudsen, Cecilie;
    • Lubberding, Anniek F.;
    • Veedfald, Simon;
    • Isaksen, Jonas L.;
    • Hartmann, Bolette;
    • Frikke‐Schmidt, Ruth;
    • Mandrup‐Poulsen, Thomas;
    • Holst, Jens J.;
    • Kanters, Jørgen K.;
    • Torekov, Signe S.
    Publication type:
    Article
    12

    The effect of curcumin on hepatic fat content in individuals with obesity.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2192, doi. 10.1111/dom.14804
    By:
    • Hellmann, Pernille H.;
    • Bagger, Jonatan I.;
    • Carlander, Katrine R.;
    • Forman, Julie;
    • Chabanova, Elizaveta;
    • Svenningsen, Jens S.;
    • Holst, Jens J.;
    • Gillum, Matthew P.;
    • Vilsbøll, Tina;
    • Knop, Filip K.
    Publication type:
    Article
    13

    Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 2017, doi. 10.1111/dom.14789
    By:
    • Wewer Albrechtsen, Nicolai J.;
    • Møller, Andreas;
    • Martinussen, Christoffer;
    • Gluud, Lise L.;
    • Rashu, Elias B.;
    • Richter, Michael M.;
    • Plomgaard, Peter;
    • Goetze, Jens P.;
    • Kjeldsen, Sasha;
    • Hansen, Lasse Holst;
    • Gustafsson, Finn;
    • Deacon, Carolyn F.;
    • Holst, Jens J.;
    • Madsbad, Sten;
    • Bojsen‐Møller, Kirstine N.
    Publication type:
    Article
    14

    Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1882, doi. 10.1111/dom.14736
    By:
    • Stensen, Signe;
    • Krogh, Liva L.;
    • Sparre‐Ulrich, Alexander H.;
    • Dela, Flemming;
    • Hartmann, Bolette;
    • Vilsbøll, Tina;
    • Holst, Jens J.;
    • Rosenkilde, Mette M.;
    • Christensen, Mikkel B.;
    • Gasbjerg, Lærke S.;
    • Knop, Filip K.
    Publication type:
    Article
    15
    16
    17
    18

    Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 115, doi. 10.1111/dom.14557
    By:
    • Muskiet, Marcel H. A.;
    • Tonneijck, Lennart;
    • Smits, Mark M.;
    • Kramer, Mark H. H.;
    • Ouwens, D. Margriet;
    • Hartmann, Bolette;
    • Holst, Jens J.;
    • Danser, A. H. Jan;
    • Joles, Jaap A.;
    • van Raalte, Daniël H.
    Publication type:
    Article
    19
    20
    21
    22
    23

    No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 530, doi. 10.1111/dom.14246
    By:
    • Clemmensen, Kim K. B.;
    • Blond, Martin B.;
    • Amadid, Hanan;
    • Bruhn, Lea;
    • Vistisen, Dorte;
    • Karstoft, Kristian;
    • Persson, Frederik;
    • Ried‐Larsen, Mathias;
    • Holst, Jens J.;
    • Wewer Albrechtsen, Nicolai J.;
    • Torekov, Signe S.;
    • Quist, Jonas S.;
    • Jørgensen, Marit E.;
    • Færch, Kristine
    Publication type:
    Article
    24

    Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 415, doi. 10.1111/dom.14233
    By:
    • Duinkerken, Eelco;
    • Bernardes, Gabriel;
    • Bloemendaal, Liselotte;
    • Veltman, Dick J.;
    • Barkhof, Frederik;
    • Mograbi, Daniel C.;
    • Gerdes, Victor E. A.;
    • Deacon, Carolyn F.;
    • Holst, Jens J.;
    • Drent, Madeleine L.;
    • Diamant, Michaela;
    • Kulve, Jennifer;
    • Ijzerman, Richard G.
    Publication type:
    Article
    25
    26
    27

    Cover Image, Volume 22, Issue 10.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1, doi. 10.1111/dom.14188
    By:
    • Svane, Maria S.;
    • Johannesen, Helle H.;
    • Martinussen, Christoffer;
    • Bojsen‐Møller, Kirstine N.;
    • Hansen, Martin Lundsgaard;
    • Hansen, Adam E.;
    • Deacon, Carolyn F.;
    • Hartmann, Bolette;
    • Keller, Sune H.;
    • Klausen, Thomas L.;
    • Loft, Annika;
    • Kjaer, Andreas;
    • Madsbad, Sten;
    • Löfgren, Johan;
    • Holst, Jens J.;
    • Wewer Albrechtsen, Nicolai J.
    Publication type:
    Article
    28

    No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1837, doi. 10.1111/dom.14106
    By:
    • Svane, Maria S.;
    • Johannesen, Helle H.;
    • Martinussen, Christoffer;
    • Bojsen‐Møller, Kirstine N.;
    • Hansen, Martin Lundsgaard;
    • Hansen, Adam E.;
    • Deacon, Carolyn F.;
    • Hartmann, Bolette;
    • Keller, Sune H.;
    • Klausen, Thomas L.;
    • Loft, Annika;
    • Kjaer, Andreas;
    • Madsbad, Sten;
    • Löfgren, Johan;
    • Holst, Jens J.;
    • Wewer Albrechtsen, Nicolai J.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial.

    Published in:
    European Journal of Nutrition, 2022, v. 61, n. 2, p. 687, doi. 10.1007/s00394-021-02674-1
    By:
    • Dicks, Lisa;
    • Jakobs, Linda;
    • Sari, Miriam;
    • Hambitzer, Reinhard;
    • Ludwig, Norbert;
    • Simon, Marie-Christine;
    • Stehle, Peter;
    • Stoffel-Wagner, Birgit;
    • Helfrich, Hans-Peter;
    • Ahlborn, Jenny;
    • Rühl, Martin;
    • Hartmann, Bolette;
    • Holst, Jens J.;
    • Ellinger, Sabine
    Publication type:
    Article
    41

    Body weight and metabolic risk factors in patients with type 2 diabetes on a self-selected high-protein low-carbohydrate diet.

    Published in:
    European Journal of Nutrition, 2021, v. 60, n. 8, p. 4473, doi. 10.1007/s00394-021-02605-0
    By:
    • Alzahrani, Ahmad H.;
    • Skytte, Mads J.;
    • Samkani, Amirsalar;
    • Thomsen, Mads N.;
    • Astrup, Arne;
    • Ritz, Christian;
    • Chabanova, Elizaveta;
    • Frystyk, Jan;
    • Holst, Jens J.;
    • Thomsen, Henrik S.;
    • Madsbad, Sten;
    • Haugaard, Steen B.;
    • Krarup, Thure;
    • Larsen, Thomas Meinert;
    • Magkos, Faidon
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50